¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"All Flow 5000 PFT Filter Misc"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® flow ÇÑ±Û È帧, À¯·®
¼³¸í   
  ¾×ü ¶Ç´Â ±âüÀÇ °¢ ºÎºÐÀÌ ½Ã°£°ú ÇÔ²² ¿¬¼ÓÀûÀ¸·Î ±× À§Ä¡¸¦ À̵¿Çϴ Çö»ó. ±× ¾ç»óÀº º¹ÀâÇÏÁö¸¸ °¢ Á¡¿¡¼­ÀÇ È帧ÀÇ ¹æÇâÀÌ ±× Á¡¿¡¼­ÀÇ Á¢¼± ¹æÇâ°ú ÀÏÄ¡Çϵµ·Ï ¼±À» ±×À¸¸é È帧ÀÇ ¸ð¾çÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ°Ô µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • barrier filter
    ¼±Åÿ©°ú±â, ¼±ÅÃÇÊÅÍ
  • biological filter
    »ý¹°ÇÐÀû¿©°ú±â, »ý¹°ÇÐÀû°Å¸£°³
  • bacteriological filter
    ¼¼±Õ¿©°ú±â, ¼¼±Õ°Å¸£°³
  • bouillon filter
    °í±âÁó¿©°ú±â, °í±âÁó°Å¸£°³
  • compensating filter
    º¸»ó¿©°ú±â, º¸»óÇÊÅÍ
  • cutoff filter
    Â÷´Ü¿©°ú±â, Â÷´Ü°Å¸£°³
  • diatomaceous earth filter
    ±ÔÁ¶Åä¿©°ú±â, ±ÔÁ¶Åä°Å¸£°³
  • filter
    ¿©°ú±â, °Å¸£°³, ÇÊÅÍ
  • flattening filter
    ÆíÆòÈ­¿©°ú±â, ÆíÆò°Å¸£°³
  • high frequency filter
    °íÁÖÆÄ¿©°ú±â, °íÁ֯İŏ£°³
  • high-pass filter
    °íÁÖÆÄÅë°ú¿©°ú±â, °íÁÖÆÄÅë°ú°Å¸£°³
  • interference filter
    °£¼·¿©°ú±â, °£¼·°Å¸£°³, °£¼·ÇÊÅÍ
  • low-pass filter
    ÀúÁÖÆÄÅë°ú¿©°ú±â, ÀúÁÖÆÄÅë°ú°Å¸£°³
  • molecular filter
    ºÐÀÚ¿©°ú±â, ºÐÀڰŸ£°³
  • membrane filter
    ¸·¿©°ú±â, ¸·°Å¸£°³, ¸·ÇÊÅÍ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • filter
    °Å¸£°³, ¿©°ú±â, ÇÊÅÍ
  • flow cytometry
    È帧¼¼Æ÷ÃøÁ¤
  • flow
    1.È帧, 2.À¯·®
  • blood flow
    Ç÷·ù
  • blood flow rate
    Ç÷·ù·®, Ç÷·ù¼Óµµ
  • peak expiratory flow rate
    ÃÖ°í³¯¼û¼Óµµ, ÃÖ°íÈ£±âÀ¯¼Ó
  • blood flow velocity
    ÇÇÈ帧¼Óµµ, Ç÷·ù¼Óµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacteriological filter
    ¼¼±Õ°Å¸£°³, ¼¼±Õ¿©°ú±â
  • barrier filter
    ¼±ÅÃÇÊÅÍ
  • biological filter
    »ý¹°ÇÐÀû°Å¸£°³
  • bouillon filter
    °í±âÁó°Å¸£°³
  • compensating filter
    º¸»óÇÊÅÍ
  • cutoff filter
    Â÷´Ü°Å¸£°³, Â÷´ÜÇÊÅÍ
  • diatomaceous earth filter
    ±ÔÁ¶Åä°Å¸£°³
  • filter
    °Å¸£°³, ¿©°ú±â, ÇÊÅÍ
  • flattening filter
    ÆíÆò°Å¸£°³, ÆíÆòÈ­¿©°ú±â
  • high frequency filter
    °íÁ֯İŏ£°³, °íÁÖÆÄ¿©°ú
  • high-pass filter
    °íÁÖÆÄÅë°ú°Å¸£°³, °íÁÖÆÄÅë°úÇÊÅÍ
  • interference filter
    °£¼·°Å¸£°³, °£¼·ÇÊÅÍ
  • low-pass filter
    ÀúÅë°ú°Å¸£°³, ÀúÅë°ú¿©°ú±â
  • membrane filter
    ¸·°Å¸£°³, ¸·ÇÊÅÍ
  • molecular filter
    ºÐÀڰŸ£°³
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Berkefeld filter
    º£¸£ÄÉÆçÆ® ¿©°ú±â
  • Chamberland filter
    ¼§º£¸£¶û °Å¸£°³.
  • HEPA filter
    HEPA ¿©°ú±â
  • arterial filter
    µ¿¸ÆÇ÷¿©°ú.
  • highpass filter
    °íÁÖÆÄÅë°úÇÊÅÍ.
  • polarizing filter
    Æí±¤ÇÊÅÍ
  • porcelain filter
    ÀÚÁ¦(í¸ð²)°Å¸£°³.
  • protective mask filter
    ¹æÈ£(ËÑÌ´)ÇÊÅÍ.
  • quantitative filter paper
    Á¤·®¿©°úÁö.
  • ELBF=£¾effective liver blood flow
    À¯È¿¼º °£Ç÷·ù.
  • ELBF=£¾effective liver blood flow
    À¯È¿ °£Ç÷·ù.
  • ERPF => effective renal plasma flow
    À¯È¿½ÅÇ÷ÀåÀ¯Åë·®
  • ERPF=£¾effective renal plasma flow
    À¯È¿½ÅÇ÷·ù·®.
  • Flow
    À¯·®(êüÕá), È帧
  • Flow-limited exchange
    À¯·®Á¦Çѱ³È¯(ð¤ùÚÎßüµ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • all-or-none law =all-or-none principle
    ´Ù³Ä ¾Æ´Ï³ÄÀÇ ¹ýÄ¢, ½Ç¹«À²
  • acute lymphatic leukemia =ALL
    ±Þ¼º ¸²ÇÁ¼º ¹éÇ÷º´(?ËÛËÑÌ´ËÓ).
  • acute lymphatic leukemia =ALL
    ±Þ¼º ¸²ÇÁ¼º ¹éÇ÷º´(¡­àõÛÜúìÜ»).
  • acute lymphoblastic leukemia=ALL
    ±Þ¼º¸²ÇÁ±¸¼º¹éÇ÷º´,
  • all cast crown
    ÀüºÎÁÖÁ¶±Ý¼Ó°ü(îïÝ»ñÑðã ÐÝáÕή).
  • all porcelain dowel crown
    ÀüºÎ µµÄ¡°ü°è ¼ÓÄ¡.
  • all porcelian bridge
    ÀüºÎ µµÀç °¡ÀÇÄ¡.
  • panacea =cure all
    ¸¸´É¾à(Ø¿Òöå·). [¾à¸®]¸¸´É¾à, ¸¸º´ÅëÄ¡¾à.
  • panacea =cure all
    ¸¸´É¾à(Ø¿Òöå·).(¾à¸®)¸¸´É¾à, ¸¸º´ÅëÄ¡¾à.
  • arterial filter
    µ¿¸ÆÇ÷¿©°ú.
  • bacterial filter
    ¼¼±Õ°Å¸£°³, ¼¼±Õ¿©°ú±â
  • bacteriological filter
    ¼¼±Õ°Å¸£°³.
  • bacteriological filter
    ¼¼±Õ°Å¸£°³.
  • bag filter
    ¹é ÇÊÅÍ.
  • barrier filter
    ¿©°úÇÊÅÍ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • filter paper slant culture
    ¿©°úÁö»ç¸é¹è¾ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Berkefeld filter
    º£¸£ÄÉÆçÆ® ¿©°ú±â(ÕëΦÐï)
  • filter
    1) °Å¸£°Ô 2) ÇÊÅÍ
  • filter affinity transfer
    °Å¸£°Ô ģȭÀüÀÌ(öÑûúï®ì¹)
  • filter fluorometer
    ÇÊÅÍ Çü±¤°è(û«ÎÃͪ)
  • filter hybridization
    ¿©Áö(æ¤òµ) Æ¢±âÇü¼º
  • filter paper chromatography
    ¿©Áö(Õëòµ) Å©·Î¸¶Åä±×·¡ÇÇ
  • filter photometer
    ÇÊÅÍ ±¤µµ°è(ÎÃÓøÍª)
  • interference filter
    °£¼·(ÊÎàï)ÇÊÅÍ
  • membrane filter
    ¸·(د)°Å¸£°Ô
  • nitrocellulose filter
    ³ªÀÌÆ®·Î¼¿·ç·Î½º ¿©Áö(æ¤òµ)
  • backward flow
    ¿ª·ù(æ½×µ)
  • backward flow interface centrifugation
    ¿ª·ù °è¸é¿ø½ÉħÀü(æ½×µ Í£ØüêÀãýöØîþ)
  • continuous flow centrifugation
    ¿¬¼Ó(ææáÙ)È帧 ¿ø½ÉºÐ¸®¹ý(êÀãýÝÂ×îÛö)
  • continuous flow electrophoresis
    ¿¬¼Ó(ææáÙ)È帧 Àü±â¿µµ¿¹ý(ï³Ñ¨ç¶ÔÑÛö)
  • continuous flow isoelectric focusing
    ¿¬¼Ó(ææáÙ)È帧 µ¿Àü(Ôõï³) Æ÷Ä«½Ì
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • all-or-none law
    ´Ù³Ä¾Æ´Ï³ÄÀÇ ¹ýÄ¢, ½Ç¹«À² ÀüºÎ-Àü¹«¿øÄ¢
  • all-or-none principle
    ´Ù³Ä¾Æ´Ï³ÄÀÇ ¿ø¸®, ½Ç¹«À²
  • cut-off filter
    Â÷´ÜÇÊÅÍ
  • low pass filter
    ÀúÅë°ú¿©°ú±â
  • wedge filter
    ½û±âÇüÇÊÅÍ
  • back flow
    ¿ª·ù
  • blood flow
    Ç÷·ù·®
  • bulk flow
    µ¢¾î¸®È帧
  • cerebrospinal fluid flow void sign
    ³úô¼ö¾×È帧¼Ò½Ç¡ÈÄ
  • co-current flow
    ¹Ù¸¥È帧, Á¤È帧
  • color Doppler flow mapping
    »öµµÇ÷¯Ç÷·ùÁöµµÈ­
  • color flow imaging
    »öÇ÷·ù¿µ»ó
  • color flow mapping
    »öÇ÷·ùÁöµµÈ­
  • counter current flow
    ¿ªÈ帧, °Å²Ù·ÎÈ帧, ¿ª·ù
  • flow
    ±â·ù, À¯·®, È帧
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
misc miscarriage; miscellaneous
CBF capillary blood flow; cerebral blood flow; ciliary beat frequency; coronary blood flow; cortical blo...
HBF hand blood flow; hemispheric blood flow; hemoglobinuric bilious fever; hepatic blood flow; hypothala...
PFT   1) Platelet Function Test
  2) Pulmonary Function Test
PFT pancreatic function test; parafascicular thalamotomy; posterior fossa tumor; prednisone, fluorouraci...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ALL-Trans RA ALL-Trans Retinoic acid
C ALL Common ALL
T-ALL T cell ALL
PFT Protein farnesyltransferase
PFT Pulmonary Function Tests
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • a laser for all reasons
    ´Ù¿ëµµÀÇ ·¹ÀÌÀú
    ¿©·¯ Á¾·ùÀÇ Á¶Á÷À» ´ë»óÀ¸·Î ´Ù¾çÇÑ Ä¡·á¸¦ ½ÃÇàÇÒ ¼ö ÀÖ´Â ·¹ÀÌÀú.
  • all cast crown
    ÀüºÎ ÁÖÁ¶°ü
  • all porcelain bridge
    ÀüºÎ µµÀç °¡°ø ÀÇÄ¡
  • all porcelian bridge
    ÀüºÎ µµÀç °¡ÀÇÄ¡
  • all-or-none principle
    ´Ù³Ä ¾Æ´Ï³ÄÀÇ ¿ø¸®, ½Ç¹«À²
  • bag filter
    ¹é ÇÊÅÍ
  • barrier filter
    °£º® ÇÊÅÍ
  • cut-off filter
    Â÷´Ü ÇÊÅÍ
  • filter paper
    °Å¸§ Á¾ÀÌ, ¿©°úÁö
  • polarizing filter
    Æí±¤ ÇÊÅÍ
  • porcelain filter
    ÀÚÁ¦ °Å¸£°³
  • Seitz Filter
    ÀÚÀÌÃ÷Çü ¼¼±Õ ¿©°ú±â
    ¼®¸éÁ¦ ¿©°úÆÇ »ç¿ë, Ç÷ûÀÇ ¸ê±Õ¿¡ ÀÌ¿ëÇÑ´Ù.
  • suction filter
    ÈíÀÎ °Å¸£°³
  • wave filter
    ¿©ÆÄ±â
  • air flow
    ±â·ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ALL <haematology> A rapidly progressing cancer of the blood affecting the type of white blood cell known as lymphocytes. Approximately 650 new cases are diagnosed every year in the UK and it is the most common form of childhood leukaemia.
Acronym: ALL
Origin: Gr. Haima = blood
(11 Nov 1997)
all or none Consistently total response to any effective stimulus.
Synonym: all or none law.
(05 Mar 2000)
all or none law Consistently total response to any effective stimulus.
Synonym: all or none law.
(05 Mar 2000)
all-or-nothing phenomenon <physiology> Refers to the phenomenon where the strength of a nerve impulse is not dependent on the strength of the stimulus. Instead, there is a threshold level of stimulus strength that must be reached before the nerve will fire an impulse (at full capacity). Below the threshold, the nerve will not fire at all.
<cardiology> It also refers to the same phenomenon observed in the heart muscle, which will either contract fully or not at all.
<psychology> In studies of behaviour, it refers to the same phenomenon where a behavioural stimulus will either produce a complete response or no response at all. Also called all-or-nothing principle, all-or-none law, all-or-none responsiveness, etc.
(15 Nov 1997)
all souls' day The second day of November; a feast day of the Roman Catholic church, on which supplications are made for the souls of the faithful dead.
Source: Websters Dictionary
(01 Mar 1998)
all-trans-retinal The orange retinaldehyde resulting from the action of light on the rhodopsin of the retina, which converts the 11-cis-retinal component of the rhodopsin to all-trans-retinal plus opsin.
Synonym: trans-retinal, visual yellow.
(05 Mar 2000)
stains-all 4,5,4',5'-Dibenzo-3,3'-diethyl-9-methylthiocarbocyanine bromide;a dye that stains phosphoproteins blue, proteins red, nucleic acids purple, and mucoproteins and mucopolysaccharides various colours on acrylamide gels; also used on tissue sections.
(05 Mar 2000)
absolute filter <apparatus> A fine-pored, steam-sterilisable filter that is used to trap airborne microorganisms. The filter's pores are about 2 micrometres in diameter, smaller than the particles it is designed to remove.
(06 May 1997)
bandpass filter A device that allows a limited range of frequencies to pass.
(05 Mar 2000)
Berkefeld filter A bacterial filter used in 1891, made of earth known as Kieselguhr taken from the name of the mine in Hanover, Germany, from which the earth was found. Ground water at this mine had a clear blue colour suggesting the use of the earth as a filter.
Origin: Berkefield, name of owner of the mine from which the material to make the filter was taken
(05 Mar 2000)
bird's nest filter A wire mesh vena cava filter.
(05 Mar 2000)
bird's nest ivc filter <radiology> Introduced 1982; Cook Inc., Bloomington, IN advantages, low profile: 14.5 Fr introducer sheath, low recurrent PE rates (1.1 - 2.7% by clinical history), low IVC thrombosis rates (2.9 - 5.0% by clinical history), placement in large diameter IVCs (not greater than40mm), free-form configuration does not require centreing in IVC disadvantages: stainless steel: ferromagnetic = magnetic susceptibility artifact, more operator dependent, difficult to place in short IVCs (need about 7cm for proper placement), prolapse of filter wires (? clinical significance) see also: indications
(12 Dec 1998)
vena cava filter A filter used for interruption of IVC to prevent pulmonary embolism; e.g., Greenfield filter.
Synonym: venocaval filter.
(05 Mar 2000)
vena-tech ivc filter <radiology> Introduced as LGM (L.G. Medical, France), 1985; FDA aprroval 1991: Vena-Tech, Evanston, IL, 6-leg conical design with 6 stabilizing side bars, biocompatible metal known as Phynox (cobalt,chromium,iron,nickel,moly) Efficacy, recurrent PE: 2-6%, IVC occlusion: 8-24%, migration: 0-12% Advantages, ease of placement, excellent clot trapping efficiency, low profile, lacks ferromagnetic activity: minimal MRI artifacts Disadvantages, incomplete opening (6-19%): decreases clot-trapping efficiency, increased incidence from IJ approach, decreased with rapid deployment, increased IVC thrombosis rates: 8% initial reports; 22-24% on subsequent reports by ultrasound/MRI: 2-19% clinically symptomatic
(12 Dec 1998)
venocaval filter A filter used for interruption of IVC to prevent pulmonary embolism; e.g., Greenfield filter.
Synonym: venocaval filter.
(05 Mar 2000)
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 1 ÆäÀÌÁö: 1
  • All Flow 5000 PFT Filter Misc - »õâ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • flow
    ¹ü¶÷ÇÏ´Ù
  • cash flow
    ij½ÃÇ÷Î(°¨°¡ »ó°¢ºñ¸¦ °¡»êÇÑ ¼øÀÌÀÍ);Çö±Ý À¯ÃâÀÔ;Çö±Ý ÀÚ±Ý
  • energy flow
    (»ýŰèÀÇ)¿¡³ÊÁö È帧
  • flow
    ¸Ó¸®Ä®ÀÌ ´Ã¾îÁö´Ù;(¹Ù¶÷¿¡)¾µ¸®´Ù;(Á¶¼ö°¡)¹Ð´Ù;¸¹ÀÌÀÖ´Ù;È帣°ÔÇÏ´Ù;¹ü¶÷½ÃŰ´Ù;È帧;À¯Ãâ·®;¹Ð¹°;È帣´Ù
  • flow diagram
    ÄÄÇ»ÅÍ ¹®Á¦Ã³¸®¸¦ À§ÇÑ ¼øÀ§Ç¥
  • flow line
    À¯¹®(È­¼º¾Ï À¯µ¿ ¶§¿¡ »ý±â´Â ÁÙ¹«´Ì)
  • flow sheet
    =FLOW DIAGRZM
  • filter
    ¿©°ú±â;¿©°úÀç;ÇÊÅÍ;°Å¸£´Ù;¿©°úÇÏ´Ù;½º¹Ì´Ù;¹è´Ù;»õ´Ù
  • filter bed
    ¿©°ú¼º;¿©°úÁö;¹° °Å¸£´Â ÅÊÅ©
  • filter center
    ´ë°ø Á¤º¸ Á¸ºÎ;Á¤º¸ ½É»ç¼Ò
  • filter cigarette
    ÇÊÅÍ ´ã¹è
  • filter paper
    ¿©°úÁö
  • filter press
    ¾ÐÂø½Ä ¿©°ú±â;»ý¼± ±â¸§ Â¥´Â ±â°è
  • filter sign
    Á÷Áø Â÷·®ÀÌ Á¤ÁöÇÏ´Â »çÀÌ¿¡
  • filter tip
    ÇÊÅÍ(´ã¹è)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á